Core Viewpoint - Rosen Law Firm is reminding investors of KinderCare Learning Companies, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's October 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased KinderCare common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 14, 2025 [3]. - The lawsuit claims that the registration statement was false and/or misleading, failing to disclose incidents of child abuse and neglect at KinderCare facilities, and that the company did not meet minimum care standards [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. due to allegations of materially misleading business information [1] Group 1: Company Information - Tandem Diabetes Care issued a press release on August 7, 2025, regarding a voluntary medical device correction for select t:slim X2 insulin pumps, addressing a potential speaker-related issue that could lead to insulin delivery discontinuation [3] - Following the announcement, Tandem Diabetes' stock experienced a significant decline of 19.9% on the same day [3] Group 2: Legal Actions - Rosen Law Firm is preparing a class action lawsuit to seek recovery of investor losses for those who purchased Tandem Diabetes Care securities, with no out-of-pocket fees for participants through a contingency fee arrangement [2] - Investors interested in joining the class action can submit their information through the Rosen Law Firm's website or contact them directly [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and consistently ranking in the top 4 for securities class action settlements since 2013 [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of V.F. Corporation securities between October 30, 2023, and May 20, 2025, alleging that the company disseminated materially false and misleading statements regarding its turnaround plans [1][5]. Group 1: Lawsuit Details - The lawsuit claims that V.F. Corporation concealed significant reset actions necessary for the Vans brand to return to growth, which negatively impacted revenue growth [5]. - Investors who purchased V.F. Corporation securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by November 12, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking in the top 4 since 2013 [4].

Core Viewpoint - A class action lawsuit has been filed against Quanex Building Products Corporation for failing to disclose significant operational issues related to its Tyman acquisition, which has led to a substantial decline in stock price following the revelation of these issues [1][2][3]. Group 1: Allegations and Issues - The lawsuit alleges that Quanex's maintenance procedures and policies at its Tyman Mexico facility were significantly underinvested, leading to degraded tooling and equipment conditions [2]. - It is claimed that the company was likely to incur significant costs due to these operational issues, which would delay the expected benefits from the Tyman integration [2]. - The complaint states that Quanex had previously identified these issues but failed to disclose them, resulting in misleading positive statements about the company's business and prospects [2]. Group 2: Stock Price Impact - Following the revelation of the operational issues, Quanex's stock price fell by $2.73, or 13.1%, closing at $18.18 per share on September 5, 2025 [3]. - The stock continued to decline, dropping an additional $1.98, or 10.9%, to close at $16.20 per share on September 8, 2025 [3].

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance, leading to a significant drop in stock price following disappointing financial results [1][2]. Summary by Relevant Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures and overall performance [1]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health problems [1]. Stock Price Impact - Following the announcement on August 8, 2025, C3.ai's stock price fell from $22.13 per share to $16.47 per share by August 11, 2025, marking a decline of approximately 25.58% in just one day [1]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates throughout the case lifecycle [2].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of RxSight, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2] Group 1: Class Action Details - The class action lawsuit has been filed against RxSight, Inc. for allegedly misleading statements regarding the company's growth and performance during the Class Period [4] - Investors who purchased RxSight securities may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2] - The lead plaintiff must file a motion with the Court by September 22, 2025, to represent other class members in the litigation [2] Group 2: Allegations Against RxSight - The lawsuit claims that RxSight misrepresented the effectiveness of its field organization and the adoption rates of newer customer cohorts, which were actually underperforming [4] - It is alleged that the utilization across the installed base was declining, contradicting the company's claims of rising utilization [4] - As a result of these misleading statements, investors purchased shares at artificially inflated prices, leading to financial damages when the truth was revealed [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [3] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [3] - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, further establishing the firm's credibility [3]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Savara Inc. securities between March 7, 2024, and May 23, 2025, alleging misleading statements regarding the company's drug application process [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Savara made false statements about the MOLBREEVI Biologics License Application (BLA), indicating it lacked sufficient information for FDA approval [5]. - It is alleged that the FDA was unlikely to approve the MOLBREEVI BLA in its current form, which could delay Savara's submission timeline and increase the need for additional capital [5]. - The lawsuit asserts that these misleading statements caused investors to suffer damages when the true information became public [5]. Group 2: Class Action Participation - Investors who purchased Savara securities during the class period may be entitled to compensation without upfront fees through a contingency fee arrangement [2]. - To join the class action, investors can submit a form online or contact the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by November 7, 2025, to represent the interests of the class members [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of KBR, Inc. securities purchasers during the specified Class Period, alleging that the company made materially false and misleading statements regarding its business operations and prospects [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to KBR, Inc. securities purchased between May 6, 2025, and June 19, 2025 [1]. - The lawsuit claims that KBR's management misrepresented the status of its partnership with the U.S. Department of Defense's Transportation Command, despite known concerns about HomeSafe's ability to fulfill contractual obligations [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by November 18, 2025, to represent the class in the litigation [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - RCI Hospitality Holdings, Inc. is under investigation for potentially issuing misleading business information, following allegations of bribery involving its executives and a New York state auditor, which has led to a significant drop in its stock price [1][3]. Group 1: Investigation and Allegations - The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of RCI Hospitality Holdings due to allegations of materially misleading business information [1]. - Allegations include that top executives of RCI Hospitality Holdings bribed a New York state auditor with trips and lap dances to avoid paying taxes, as reported by The New York Times [3]. Group 2: Stock Impact - Following the news of the bribery allegations, RCI Hospitality Holdings' stock experienced a decline of 16% on September 16, 2025 [3]. Group 3: Legal Actions - The Rosen Law Firm is preparing a class action lawsuit to seek recovery of investor losses, allowing affected shareholders to join without upfront costs [2].

Core Viewpoint - A class action lawsuit has been filed against Fly-E Group, Inc. for allegedly making false and misleading statements regarding its lithium battery technology and its impact on the company's revenue from electric vehicles [1][3]. Summary by Relevant Sections Class Action Details - The lawsuit seeks to recover losses for investors who purchased Fly-E securities between July 15, 2025, and August 14, 2025 [1]. - Investors have until November 7, 2025, to seek appointment as lead plaintiff if they suffered losses during the Class Period [2]. Allegations Against Fly-E Group - The lawsuit claims that Fly-E Group and certain officers failed to disclose safety issues with their lithium battery technology while making positive public statements [3]. - Allegations include that these undisclosed safety and regulatory concerns negatively affected revenue from the company's electric vehicle business, including e-bikes and e-scooters [3]. - The complaint also asserts that the company's forecasts lacked a reasonable basis, failing to account for rising operating costs, supply chain risks, and demand fluctuations [3]. - Following the revelation of these issues, the company's stock price declined as investors reacted to the disclosures [3].